Holen Sie sich die Stockscreener-App
1.73
4.22%
0.07
Metagenomi Inc Aktie (MGX) Neueste Nachrichten
Nuveen Asset Management LLC Buys Shares of 63,248 Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi Being Investigated on Behalf of Metagenomi, Inc. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
Adverum Biotechnologies (NASDAQ:ADVM) versus Metagenomi (NASDAQ:MGX) Head-To-Head Analysis - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 11,730 Shares of Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi, Inc. (NASDAQ:MGX) Short Interest Down 18.9% in May - Defense World
Citadel Advisors LLC Decreases Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Northern Trust Corp Raises Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
What is HC Wainwright’s Forecast for Metagenomi Q2 Earnings? - Defense World
Equities Analysts Issue Forecasts for Metagenomi Q1 Earnings - Defense World
Metagenomi Inc (NASDAQ: MGX): Finding Hidden Gems Among Volatility - Stocksregister
MGX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Metagenomi, Inc. investment - ACCESS Newswire
Price T Rowe Associates Inc. MD Buys New Holdings in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Chardan Capital Has Lowered Expectations for Metagenomi (NASDAQ:MGX) Stock Price - Defense World
Metagenomi, Inc. (NASDAQ:MGX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
Voya Investment Management LLC Acquires Shares of 10,314 Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Demystifying Metagenomi: Insights From 4 Analyst Reviews - Benzinga
Chardan Cuts Price Target on Metagenomi to $12 From $13, Keeps Buy Rating - marketscreener.com
Metagenomi, Inc. (NASDAQ:MGX) Shares Bought by Barclays PLC - Defense World
Metagenomi price target lowered to $16 from $20 at Wells Fargo - TipRanks
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing ... - Bluefield Daily Telegraph
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025 - Yahoo Finance
Metagenomi Presents Data Highlighting Advancements in - GlobeNewswire
Metagenomi (MGX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Metagenomi: Q1 Earnings Snapshot - San Francisco Chronicle
Metagenomi reports Q1 EPS (68c), consensus (51c) - TipRanks
Metagenomi Reports Positive NHP Study Results for Hemophilia A Program and Quarterly Financials - Nasdaq
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results - The Manila Times
Metagenomi Q1 Earnings: Breakthrough Hemophilia Treatment Maintains 75% Effectiveness After 19 Months - Stock Titan
Metagenomi (MGX) and Its Competitors Head-To-Head Review - Defense World
Metagenomi (MGX) Projected to Post Earnings on Tuesday - Defense World
Metagenomi, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsMGX - ACCESS Newswire
Metagenomi, Inc. (MGX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Levi & Korsinsky Notifies Shareholders of Metagenomi, Inc.(MGX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Wells Fargo & Company MN Increases Stake in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
MGX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Metagenomi, Inc. - ACCESS Newswire
Metagenomi Being Investigated on Behalf of Metagenomi, Inc. Investors. Contact Levi & Korsinsky For Details. - ACCESS Newswire
Renaissance Technologies LLC Has $555,000 Stock Holdings in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
JPMorgan Chase & Co. Acquires 65,020 Shares of Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi Inc [MGX] stock for 1,744 USD was sold by Wein Matthew - knoxdaily.com
Metagenomi Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com
Market Update: Metagenomi Inc (MGX) Sees Negative Movement, Closing at 1.49 - DWinneX
Metagenomi to Present at Upcoming Scientific Meetings - GlobeNewswire
Press Release Distribution & PR Platform - ACCESS Newswire
Metagenomi Inc (NASDAQ: MGX)’s -10.37-Percent Loss Of This Past Week Taught Us Something New - Marketing Sentinel
Geode Capital Management LLC Has $2.12 Million Stock Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MGX - ACCESS Newswire
Lost Money on Metagenomi, Inc.(MGX)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMGX - ACCESS Newswire
1.21%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):